End-of-day quote
Taiwan S.E.
18:00:00 2024-05-14 EDT
|
5-day change
|
1st Jan Change
|
48.9
TWD
|
+2.73%
|
|
+7.47%
|
+22.25%
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
2,551
|
2,868
|
2,725
|
3,268
|
3,766
|
3,781
|
Enterprise Value (EV)
1 |
1,900
|
2,203
|
2,081
|
2,716
|
3,450
|
3,521
|
P/E ratio
|
35.2
x
|
25
x
|
28.2
x
|
36.1
x
|
24
x
|
13.3
x
|
Yield
|
2.6%
|
3.74%
|
3.21%
|
3.05%
|
3.41%
|
3.99%
|
Capitalization / Revenue
|
3.84
x
|
4.27
x
|
4.59
x
|
6.87
x
|
6.03
x
|
6.62
x
|
EV / Revenue
|
2.86
x
|
3.28
x
|
3.51
x
|
5.71
x
|
5.52
x
|
6.16
x
|
EV / EBITDA
|
29.6
x
|
58.2
x
|
62.2
x
|
74.4
x
|
85.8
x
|
504
x
|
EV / FCF
|
137
x
|
47.3
x
|
31.5
x
|
166
x
|
-28.8
x
|
59
x
|
FCF Yield
|
0.73%
|
2.11%
|
3.17%
|
0.6%
|
-3.47%
|
1.7%
|
Price to Book
|
1.13
x
|
1.24
x
|
1.18
x
|
1.4
x
|
1.55
x
|
1.46
x
|
Nbr of stocks (in thousands)
|
150,952
|
150,952
|
150,952
|
150,952
|
150,952
|
150,952
|
Reference price
2 |
16.90
|
19.00
|
18.05
|
21.65
|
24.95
|
25.05
|
Announcement Date
|
3/12/18
|
3/25/19
|
3/9/20
|
3/10/21
|
3/11/22
|
3/13/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
1 |
663.8
|
671.6
|
593.2
|
475.6
|
624.6
|
571.5
|
EBITDA
1 |
64.22
|
37.83
|
33.47
|
36.53
|
40.21
|
6.981
|
EBIT
1 |
45.84
|
19.26
|
14.26
|
17.28
|
26.27
|
-7.337
|
Operating Margin
|
6.91%
|
2.87%
|
2.4%
|
3.63%
|
4.21%
|
-1.28%
|
Earnings before Tax (EBT)
1 |
80.24
|
116.8
|
98.29
|
94.14
|
160.5
|
284.6
|
Net income
1 |
73.03
|
115.5
|
96.46
|
91.43
|
157.5
|
285.9
|
Net margin
|
11%
|
17.19%
|
16.26%
|
19.22%
|
25.21%
|
50.03%
|
EPS
2 |
0.4800
|
0.7600
|
0.6390
|
0.6000
|
1.040
|
1.890
|
Free Cash Flow
1 |
13.82
|
46.55
|
66.03
|
16.32
|
-119.9
|
59.68
|
FCF margin
|
2.08%
|
6.93%
|
11.13%
|
3.43%
|
-19.19%
|
10.44%
|
FCF Conversion (EBITDA)
|
21.52%
|
123.07%
|
197.29%
|
44.69%
|
-
|
854.92%
|
FCF Conversion (Net income)
|
18.92%
|
40.32%
|
68.45%
|
17.85%
|
-
|
20.87%
|
Dividend per Share
2 |
0.4400
|
0.7100
|
0.5800
|
0.6600
|
0.8500
|
1.000
|
Announcement Date
|
3/12/18
|
3/25/19
|
3/9/20
|
3/10/21
|
3/11/22
|
3/13/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
652
|
665
|
644
|
552
|
316
|
261
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
13.8
|
46.6
|
66
|
16.3
|
-120
|
59.7
|
ROE (net income / shareholders' equity)
|
3.22%
|
5.05%
|
4.18%
|
3.94%
|
6.61%
|
11.4%
|
ROA (Net income/ Total Assets)
|
1.17%
|
0.49%
|
0.36%
|
0.44%
|
0.65%
|
-0.17%
|
Assets
1 |
6,231
|
23,527
|
26,684
|
20,918
|
24,300
|
-166,322
|
Book Value Per Share
2 |
15.00
|
15.30
|
15.20
|
15.50
|
16.10
|
17.10
|
Cash Flow per Share
2 |
3.960
|
4.050
|
3.910
|
3.300
|
1.540
|
1.210
|
Capex
1 |
3.13
|
7.31
|
5.39
|
7
|
7.27
|
11.1
|
Capex / Sales
|
0.47%
|
1.09%
|
0.91%
|
1.47%
|
1.16%
|
1.95%
|
Announcement Date
|
3/12/18
|
3/25/19
|
3/9/20
|
3/10/21
|
3/11/22
|
3/13/23
|
|
1st Jan change
|
Capi.
|
---|
| +22.25% | 222M | | +17.44% | 66.22B | | +3.54% | 49.24B | | +18.03% | 41.4B | | +20.84% | 26.62B | | +13.22% | 19.84B | | +2.07% | 17.44B | | -11.70% | 15.92B | | -23.54% | 15.57B | | +2.57% | 15.45B |
Other Specialty Chemicals
|